Table 1: Postoperative morbidity-mortality database in patients with peritoneal surface malignancy treated by cytoreductive surgery, hyperthermic intraperitoneal cisplatin and doxorubicin, and simultaneous intravenous ifosfamide. Eight categories of events and 47 adverse outcomes were scored.

CategoryAdverse event

GastrointestinalAnastomotic failure
Fistula
Pancreatic fistula
Pancreatitis
Bile leak from liver surface
Hartmann pouch blowout
Enterostomy tube complication
Oral pain/ulceration
Nausea/vomiting
Diarrhea
Ascites
Other
PulmonaryRespiratory distress
Pleural effusion
Pneumonia
ARDS
Chest tube removal
Other
Intravenous catheter statusLine sepsis
Line thrombosis
Insertion pneumothorax
Total parenteral nutrition intolerance
Other
CardiovascularRhythm
Hypotension
Ischemia
Pulmonary embolism
Thrombophlebitis
Venous thrombosis
Pulmonary edema
5-Fluorouracil cardiac toxicity
Other
GenitourinaryUrinary tract infection
Urine leak
Other
HematologicalWBC
Platelets
Postoperative hemorrhage
Units of fresh-frozen plasma
Other
NeurotoxicityState of communication
Orientation/intellect
Stroke
Other
InfectionIntra-abdominal infection
Wound infection
Other

ARDS: acute respiratory distress syndrome; WBC: white blood cell count.